Kura Oncology KURA Cash Flow Statement (2009-2026)

NASDAQ KURA
$7.73 +0.16 (+2.11%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Kura Oncology Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Kura Oncology reported cash from operations of -$54.44M and free cash flow of -$54.89M for the quarter ended Sep 2026, up 32.5% year over year. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-32.74M-32.45M-34.77M-35.50M-33.11M-34.07M-37.17M-38.60M-42.79M-49.53M-50.84M-54.40M-19.22M-57.43M-66.12M-74.12M-81.00M-73.33M-68.33M-70.22M
Depreciation and DepletionDep. & Depletion
0.21M0.18M0.18M0.19M0.25M0.21M0.21M0.22M0.21M0.23M0.20M0.21M0.20M0.24M0.22M0.16M0.40M0.36M0.37M0.33M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.12M0.12M0.12M0.12M0.12M0.13M0.13M0.14M0.13M0.14M0.14M0.10M0.11M0.11M0.12M
Depreciation & Amortization (CF)Dep. & Amort.
0.21M0.18M0.18M0.19M0.25M0.21M0.21M0.22M0.21M0.23M0.20M0.21M0.20M0.24M0.22M0.16M0.40M0.36M0.37M0.33M
Share-based CompensationStock Comp.
6.40M6.65M6.51M6.36M6.81M6.84M6.99M7.09M7.17M8.51M8.43M8.32M8.63M7.84M6.95M10.97M11.35M8.42M8.21M8.17M
Gains from Equity InvestmentsGains Equity
-30.59M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
-0.40M
Change in Working Capital
Change in ReceivablesChange Receivables
46.69M-44.17M31.36M-27.13M0.54M0.10M5.04M
Change in InventoryChange Inventory
0.43M1.64M2.50M
Change in Account PayablesChange Payables
3.14M-2.91M2.97M1.30M2.03M-4.65M5.70M
Change in Accrued ExpensesChange Accrued Exp.
0.03M-5.25M-0.34M6.35M-1.56M-5.36M4.11M3.93M8.57M-3.13M-0.05M5.68M14.33M-8.61M10.41M9.81M1.05M-16.22M9.66M12.17M
Change in Other Operating AssetsOther Assets Change
-1.88M2.63M2.57M-0.91M-1.35M2.11M-1.88M-0.80M2.53M2.19M-2.46M-0.36M7.48M1.04M7.51M10.29M-2.89M0.56M-4.34M-5.49M
Change in Other Operating LiabilitiesOther Liabilities Change
0.02M0.12M-0.04M0.08M0.02M0.01M0.03M0.03M0.06M0.17M0.14M0.21M278.41M34.90M-10.44M15.90M156.40M-5.46M-10.11M-8.57M
Other Working Capital ChangesOther WC Changes
1.90M-2.51M-2.61M1.00M1.37M-2.10M1.92M0.83M-2.47M-2.02M2.61M0.57M270.93M33.86M-17.96M5.61M159.29M-6.02M-5.78M-3.08M
Cash from OperationsCash from Ops.
-23.37M-32.18M-30.34M-21.01M-26.53M-35.87M-25.62M-29.03M-34.31M-48.84M-42.53M-43.44M269.13M-71.93M-28.78M-80.63M117.27M-85.85M-62.55M-54.44M
Investing Activities
Capital ExpendituresCapex
0.10M0.05M0.18M0.38M0.01M0.04M0.10M0.02M0.02M0.08M0.02M0.37M0.29M1.46M2.57M2.32M0.13M0.66M0.45M
Change in Property, Plant and EquipmentChange in PP&E
-0.10M-0.05M-0.18M-0.38M-0.01M-0.04M-0.10M-0.02M-0.02M-0.08M-0.02M-0.37M-0.29M-1.46M-2.57M-2.32M-0.13M-0.66M-0.45M
Purchase of InvestmentsInvestments Purchased
16.34M51.40M56.18M56.95M106.12M73.84M139.63M96.67M99.69M195.06M161.67M61.73M240.58M268.71M114.60M138.50M239.78M171.60M19.64M117.46M
Sale and Maturity of InvestmentsInvestments Sold
90.50M26.49M89.46M129.14M58.82M85.00M93.40M105.25M141.90M99.81M204.86M107.26M146.00M167.60M175.00M235.03M177.50M147.50M112.50M127.50M
Cash from Investing ActivitiesCash from Investing
74.06M-24.96M33.10M71.81M-47.32M11.13M-46.33M8.56M42.20M-95.34M43.17M45.54M-94.96M-101.41M58.94M93.97M-64.60M-24.23M92.21M9.60M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.79M0.30M2.67M0.88M25.29M0.69M148.37M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M32.54M
Net Shares Issued and RepurchasedNet Shares Issued
0.79M0.30M2.67M0.88M25.29M0.69M148.37M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M32.54M
Net Equity Issued and RepurchasedNet Equity Issued
0.79M0.30M2.67M0.88M25.29M0.69M148.37M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M32.54M
Cash from Financing ActivitiesCash from Financing
0.79M0.30M2.67M0.88M34.71M0.08M0.69M148.37M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M32.54M
Additional items
Change in Cash
51.49M-56.84M5.43M51.68M-39.14M-24.74M22.07M-20.38M8.58M4.19M3.68M4.30M174.98M-173.19M30.68M13.34M53.81M-110.02M31.16M-12.31M
Ending Cash Balance
90.67M34.04M39.47M90.94M51.80M27.06M49.12M28.74M37.32M41.51M45.18M49.48M224.46M51.27M81.95M95.29M149.10M39.08M70.24M57.94M
Free Cash FlowFCF
-23.47M-32.23M-30.53M-21.39M-26.54M-35.91M-25.71M-29.05M-34.32M-48.93M-42.55M-43.44M268.76M-72.22M-30.24M-83.19M114.95M-85.98M-63.21M-54.89M
Net Cash FlowNCF
51.49M-56.84M5.43M51.68M-39.14M-24.74M-71.94M-20.38M8.58M4.19M3.68M4.30M174.98M-173.19M30.68M13.34M53.81M-110.02M31.16M-12.31M
Interest Paid

Kura Oncology Cash Flow Statement API

Pull Kura Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KURA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY